Home › Funds › Tweedy, Browne Co LLC › VRTX

Tweedy, Browne Co LLC position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

Tweedy, Browne Co LLC reported holding 26,013 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$13.6M, representing 1.11% of its reported portfolio and ranking #19 among its reported holdings. Tweedy, Browne Co LLC has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)26.01K sh
Reported value held$13.60M
Portfolio Weight1.11%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Tweedy, Browne Co LLC's VRTX position evolved

Tweedy, Browne Co LLC first disclosed a stake in VRTX in Q3 2023 at 75,004 shares (US$26.1M). The position peaked in Q1 2024 at 66,699 shares, worth US$27.9M. Across 13 filings, Tweedy, Browne Co LLC increased the stake 2 time(s), trimmed it 8 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 26,013 shares valued at US$13.6M — a reduction of -14,108 shares quarter over quarter.. Notable position changes include a 35% trim in Q3 2026 (shares rose 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 75.00K $26.08M New
Q4 2023 66.76K $27.17M Reduce
Q1 2024 66.70K $27.88M Hold
Q2 2024 54.35K $25.47M Reduce
Q3 2024 53.60K $24.93M Reduce
Q4 2024 40.63K $16.36M Reduce
Q1 2025 38.32K $18.58M Reduce
Q2 2025 37.25K $16.59M Reduce
Q3 2025 39.06K $15.30M Add
Q4 2025 39.15K $17.75M Hold
Q1 2026 40.39K $18.03M Add
Q2 2026 40.12K $19.93M Reduce
Q3 2026 26.01K $13.60M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 32 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$13.58B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has Tweedy, Browne Co LLC held VRTX?

Tweedy, Browne Co LLC has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Tweedy, Browne Co LLC's current position in VRTX?

As of Q3 2026, Tweedy, Browne Co LLC holds 26.01K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $13.60M, representing 1.11% of its reported portfolio and ranking #19.

Has Tweedy, Browne Co LLC been buying or selling VRTX?

In the latest 13F filing (Q3 2026), Tweedy, Browne Co LLC reduced its position in VRTX. The position peaked in Q1 2024 at 66.70K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.